MAPK1 and head and neck squamous cell carcinoma: As for resistance to radiotherapy, a German oropharyngeal cancer study (N = 124) showed that elevated p-Erk1/2 expression levels was associated with poor clinical outcomes, suggesting the potential involvement of ERK activation in HNSCC radioresistance92.